Central Serous Chorioretinopathy
📧 Sign up to get email alerts when something new happens for Central Serous Chorioretinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy [Phase 2, Phase 3]
A clinical trial evaluating intravitreal bevacizumab for central serous chorioretinopathy (Phase 2/3) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-14Clinical Trial Update: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD [NA]
A clinical trial comparing intravitreal bevacizumab versus combination therapy for choroidal neovascularization due to conditions other than…